Verastem | VSTM - Gross Profit On Sales

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $545K in Gross Profit on Sales for its fiscal quarter ending in December of 2021.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
AstraZeneca USD 12.39B 5M Dec/2025
Curis USD -7.72M 140K Jun/2024
Cytokinetics USD 1.94M 64.83M Sep/2025
Gilead Sciences USD 6.31B 106M Dec/2025
Incyte USD 1.39B 118.68M Dec/2025
Laboratory Of America USD 1.03B 21.1M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
TG Therapeutics USD 133.62M 11.41M Sep/2025
Verastem USD 545K 543K Dec/2021